Notice NOT-OD-23-088 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-084 from the NIH Guide for Grants and Contracts

Notice NOT-MH-23-215 from the NIH Guide for Grants and Contracts

Notice NOT-DK-23-011 from the NIH Guide for Grants and Contracts

Notice NOT-DE-23-006 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HS-23-010 from the NIH Guide for Grants and Contracts. The purpose of this funding announcement is to invite proposals focused on understanding and improving diagnostic safety in the heterogenous ambulatory care environment. AHRQ is interested in learning the incidence and contributory factors of diagnostic error within and across the array of ambulatory care services.

Funding Opportunity RFA-HS-23-011 from the NIH Guide for Grants and Contracts. The purpose of this funding announcement is to invite proposals focused on understanding and improving diagnostic safety in the heterogenous ambulatory care environment. AHRQ is interested in providing support designed to develop, test, and evaluate primary care activities that will improve diagnostic safety and quality.

Funding Opportunity RFA-DK-22-038 from the NIH Guide for Grants and Contracts. This NIDDK Funding Opportunity Announcement will support pilot and feasibility trials to test interventions that involve screening for and addressing adverse social determinants of health (SDoH), also called social risks, during a health care visit. Patients endorsed social needs could be addressed by appropriately referring/navigating patients or caregivers to resources that address these issues at social service organizations located externally or co-located in the healthcare system. The trials will determine 1) feasibility and acceptability of screening for social risks, identifying social needs and implementing referral service linkages (e.g., addressing transportation and housing needs, food insecurity, etc.) within the context of a healthcare visit, and 2) preliminary signals of the interventions impact on both the social risk/need(s) and NIDDK disease outcomes. Preliminary data regarding intervention efficacy are not required. The proposed pilot and feasibility clinical trials should lay the foundation for larger clinical trials to integrate social care and medical care and improve health outcomes related to the prevention and/or treatment of diseases within the mission of NIDDK. It is expected that these pilot studies will begin to delineate promising practices for future equitable and effective real world implementation of social and medical care integration. The overarching goal of this FOA is to develop pragmatic approaches that can be used in health care settings to reduce health disparities in diseases within the mission of NIDDK and achieve health equity, especially among individuals from racial and ethnic minority groups, rural populations, sexual and gender minority groups, and other socioeconomically disadvantaged and medically underserved communities.

Notice NOT-DA-23-017 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DK-23-006 from the NIH Guide for Grants and Contracts. The impact of pain on patient quality of life for diseases and conditions within the mission of the NIDDK is enormous. Despite prior research efforts, our understanding of the underlying biological and clinical contributors of pain remains limited. In addition, new clinical management strategies that better measure, predict, and target pain and improve upon current interventions, such as opioids, are critically needed. The current Funding Opportunity Announcement will address these needs through solicitation of broad investigator-initiated research projects proposing novel basic, translational, and clinical studies and efforts to develop new approaches to assess and treat pain for disorders within the NIDDK's mission. Investigations are expected to provide important new insights into the pathophysiology and clinical features of pain and foster new and improved treatment and pain management strategies for patients.

Funding Opportunity RFA-AG-24-020 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite R61/R33 applications proposing to establish and conduct a networking and infrastructure project to enhance the development of comparative research on determinants of differences among human and nonhuman primate life spans, life histories, and other aging-related outcomes, and prospects for translating findings from this research into development of human interventions.

Funding Opportunity RFA-AG-24-019 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to invite R01 applications proposing comparative studies of human and nonhuman primate species with differing life spans to identify factors whose cross-species variation may contribute to differences in species life span and health span. Foci of such studies may include (but are not limited to) factors contributing to humans greater life span compared to other primates. Studies that involve primary in vivo or in vitro data generation and/or analyses of existing data or biospecimens are encouraged.

Funding Opportunity RFA-MD-23-007 from the NIH Guide for Grants and Contracts. This initiative will support research projects to test interventions to promote antiretroviral therapy (ART) initiation, ART adherence, and suppressed viral load for people living with HIV (PLWH) from health disparity populations who live in geographic areas with a high rate of new HIV infections and are engaged in HIV care.

Funding Opportunity RFA-MD-23-008 from the NIH Guide for Grants and Contracts. This initiative will support research projects that test the effectiveness of multi-level interventions to prevent HIV in high-risk health disparity populations or subgroups in one or more geographic areas with a high rate of new HIV infections.

Notice NOT-NR-23-008 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-057 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-23-100 from the NIH Guide for Grants and Contracts. The National Institute of General Medical Sciences (NIGMS) invites applications for Institutional Development Award (IDeA) Networks of Biomedical Research Excellence (INBRE) awards from investigators at biomedical research institutions that award doctoral degrees in the health sciences or sciences related to health or at independent biomedical research institutes with ongoing biomedical research programs funded by the NIH or other Federal agencies within the IDeA- eligible states. The purpose of the INBRE program is to augment and strengthen the biomedical research capacity of IDeA-eligible states. The INBRE program represents a collaborative effort to sponsor research between research intensive institutions and primarily undergraduate institutions, community colleges, and Tribally Controlled Colleges and Universities (TCCUs), as appropriate.

Funding Opportunity RFA-AG-24-011 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications to establish a coordinating center that will serve as a centralized hub for accessing, harmonizing, linking, and sharing environmental contextual data and individual exposure data with NIA/NIH-funded projects in order to foster collaboration and accelerate life course research on the social, behavioral, psychological, and economic exposures that shape Alzheimers disease and related dementias (AD/ADRD) outcomes and inequities. Applications to establish the AD/ADRD Exposome Coordinating Center (AD/ADRD Exposome CC) should identify five to seven social, behavioral, psychological, and economic exposome domains relevant to AD/ADRD, and describe activities related to the domains that will achieve the three objectives of this FOA: Develop an organizational and governance structure to support the administration, innovation, and dissemination functions of the AD/ADRD Exposome CC. Propose activities to establish guidance and practices for the use and harmonization of exposure data across NIA-supported infrastructure projects, as well as other longitudinal studies of aging. Propose and support activities for the development of innovative and novel exposure measures and data. Disseminate resources and products developed by the AD/ADRD Exposome CC to the broader AD/ADRD research community to expand the use of social and behavioral data and harmonized measures in a wide range of studies.

Funding Opportunity RFA-NS-24-001 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity is to enable multi-site clinical validation of a multimodal set of neuroimaging and biospecimen biomarkers to differentially diagnosis three or more similarly presenting neurodegenerative diseases, including at least one of the Alzheimers Disease and Related Dementias (ADRDs). As part of the program deliverables, investigators will be required to work towards qualifying the candidate biomarkers as therapeutic/drug development tools through the FDAs Biomarker Qualification Program. *Note this FOA has changed Council. ICs that previously joined are already in Shared Interest.

Funding Opportunity RFA-AI-23-008 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to advance vaccine candidates for gonorrhea, chlamydia and syphilis by supporting IND-enabling activities. Applications must include a Product Development Strategy.